Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ICU MedicalSTU:IC7 80 OCF Margin % is 14.53% as of Jun. 2026, which is 45% above its 10-year median of 10.01. GuruFocus rates STU:IC7 with a GF Score™ of 80/100 and a GF Value™ of €105.79 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 813 Medical Devices & Instruments companies, ICU Medical ranks better than 60.64% on this metric.
The historical rank and industry rank for ICU Medical's OCF Margin % or its related term are showing as below:
STU:IC7'
s OCF Margin % Range Over the Past 10 Years
Min: -2.72 Med: 10.01 Max: 23.71
Current: 10.95
During the past 13 years, the highest OCF Margin % of ICU Medical was 23.71%. The lowest was -2.72%. And the median was 10.01%.
STU:IC7's OCF Margin % is ranked better than 60.64% of 813
companies
in the Medical Devices & Instruments industry
Industry Median: 5.67
vs STU:IC7: 10.95
The historical data trend for ICU Medical's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:IC7 vs NVST, MMSI, MMED: OCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, ICU Medical's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ICU Medical OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ICU Medical's OCF Margin % distribution charts can be found below:
* The bar in red indicates where ICU Medical's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ICU Medical (STU:IC7) has a OCF Margin % of 14.53% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on ICU Medical and its competitors. This is 45% above median its historical median of 10.01. According to the industry distribution chart, ICU Medical ranks #320 out of 813 companies in the Medical Devices & Instruments industry, placing it in the top 39.4%.
Is ICU Medical's OCF Margin % too high?
ICU Medical's current OCF Margin % of 14.53% is 45% above median its 10-year median of 10.01. The Medical Devices & Instruments industry median OCF Margin % is 5.67. ICU Medical's value of 14.53% is 156.3% above this industry median. Based on the distribution chart, ICU Medical ranks #320 out of 813 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, ICU Medical has a GF Score™ of 80/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ICU Medical's OCF Margin % compare to NVST and MMSI?
According to the Medical Devices & Instruments industry distribution chart, ICU Medical ranks #320 out of 813 companies for OCF Margin %. This puts ICU Medical in the upper half of its industry. The industry median OCF Margin % is 5.67. ICU Medical's value of 14.53% is 156.3% above this benchmark. While the company's 10-year median is 10.01 vs. the industry median of 5.67, ICU Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.67, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ICU Medical's current OCF Margin % of 14.53% is 156.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on ICU Medical and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ICU Medical's current OCF Margin % is 14.53%, which is 45% above median its own 10-year median of 10.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ICU Medical stock overvalued right now?
Based on GuruFocus' analysis, ICU Medical (STU:IC7) is currently considered Significantly Overvalued. The stock's GF Value™ is €105.79, compared to a current price of €158.00 — trading 49.4% above its estimated fair value. The current OCF Margin % is 14.53%, which is 45% above median its 10-year median of 10.01 and 156.3% above the Medical Devices & Instruments industry median of 5.67. ICU Medical's overall GF Score™ is 80/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For ICU Medical (STU:IC7), the current OCF Margin % is 14.53% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ICU Medical (STU:IC7) Overvalued in 2026?
Based on GuruFocus' analysis, ICU Medical stock appears to be overvalued.
The current stock price of €158.00 is trading 49.4% above its estimated GF Value™ of €105.79.
GuruFocus considers ICU Medical to be Significantly Overvalued.
Key valuation signals for STU:IC7:
OCF Margin %: 14.53% (45% above median its 10-year median of 10.01)
GF Value™: €105.79 vs. price of €158.00 (49.4% above fair value)
Industry Position: 156.3% above the Medical Devices & Instruments median (#320 of 813)
No single metric tells the full story. See the STU:IC7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.
80GF Score
Get the complete analysis for STU:IC7
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:IC7 has been successfully added to your 
